114 related articles for article (PubMed ID: 7496603)
1. Vinblastine and 5-fluorouracil sensitivity of xenografts of four pancreatic ductal adenocarcinomas: is there a correlation with histological and cytological tumour differentiation?
Vergeylen A; Klöppel G
Virchows Arch; 1995; 427(3):317-22. PubMed ID: 7496603
[TBL] [Abstract][Full Text] [Related]
2. Phenotypical changes of a human pancreatic adenocarcinoma cell line after selection on laminin-1/nidogen (LM/Ng) substratum.
Paddenberg R; Flocke K; Elsässer HP; Lesch G; Heidtmann HH; Mannherz HG
Eur J Cell Biol; 1998 Aug; 76(4):251-64. PubMed ID: 9765055
[TBL] [Abstract][Full Text] [Related]
3. Human ductal adenocarcinomas of the pancreas express extracellular matrix proteins.
Löhr M; Trautmann B; Göttler M; Peters S; Zauner I; Maillet B; Klöppel G
Br J Cancer; 1994 Jan; 69(1):144-51. PubMed ID: 8286197
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral chemotherapy with a sustained-release drug delivery system inhibits growth of human pancreatic cancer xenografts.
Smith JP; Stock E; Orenberg EK; Yu NY; Kanekal S; Brown DM
Anticancer Drugs; 1995 Dec; 6(6):717-26. PubMed ID: 8845483
[TBL] [Abstract][Full Text] [Related]
5. Growth behavior of human pancreatic carcinoma xenograft correlates with nuclear features.
Coen H; Kint H; Kuyper CF; Jonges GN; Dumarey N; Pauwels M; Kloppel G; Roels F
Cytometry; 1992; 13(7):775-81. PubMed ID: 1333397
[TBL] [Abstract][Full Text] [Related]
6. Structural analysis of a new highly metastatic cell line PaTu 8902 from a primary human pancreatic adenocarcinoma.
Elsässer HP; Lehr U; Agricola B; Kern HF
Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 64(4):201-7. PubMed ID: 8287116
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterisation of two cell lines with different grade of differentiation derived from one primary human pancreatic adenocarcinoma.
Elsässer HP; Lehr U; Agricola B; Kern HF
Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 61(5):295-306. PubMed ID: 1348891
[TBL] [Abstract][Full Text] [Related]
8. Histological and fine structural features of pancreatic ductal adenocarcinomas in relation to growth and prognosis: studies in xenografted tumours and clinico-histopathological correlation in a series of 75 cases.
Klöppel G; Lingenthal G; von Bülow M; Kern HF
Histopathology; 1985 Aug; 9(8):841-56. PubMed ID: 2997015
[TBL] [Abstract][Full Text] [Related]
9. Expression and function of receptors for extracellular matrix proteins in human ductal adenocarcinomas of the pancreas.
Löhr M; Trautmann B; Göttler M; Peters S; Zauner I; Maier A; Klöppel G; Liebe S; Kreuser ED
Pancreas; 1996 Apr; 12(3):248-59. PubMed ID: 8830331
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
Pegram M; Hsu S; Lewis G; Pietras R; Beryt M; Sliwkowski M; Coombs D; Baly D; Kabbinavar F; Slamon D
Oncogene; 1999 Apr; 18(13):2241-51. PubMed ID: 10327070
[TBL] [Abstract][Full Text] [Related]
11. Comparative antitumour activity of vinblastine-isoleucinate and related vinca alkaloids in human tumour xenografts.
Hendriks HR; Langdon S; Berger DP; Breistøl K; Fiebig HH; Fodstad O; Schwartsmann G
Eur J Cancer; 1992; 28A(4-5):767-73. PubMed ID: 1524896
[TBL] [Abstract][Full Text] [Related]
12. p53 accumulation confers prognostic information in resectable adenocarcinomas with ductal but not with intestinal differentiation in the pancreatic head.
Bergan A; Gladhaug IP; Schjolberg A; Bergan AB; Clausen OP
Int J Oncol; 2000 Nov; 17(5):921-6. PubMed ID: 11029493
[TBL] [Abstract][Full Text] [Related]
13. Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer.
Ikeda H; Taira N; Nogami T; Shien K; Okada M; Shien T; Doihara H; Miyoshi S
Cancer Sci; 2011 Nov; 102(11):2038-42. PubMed ID: 21801281
[TBL] [Abstract][Full Text] [Related]
14. Retinoids: effects on growth, differentiation, and nuclear receptor expression in human pancreatic carcinoma cell lines.
Rosewicz S; Stier U; Brembeck F; Kaiser A; Papadimitriou CA; Berdel WE; Wiedenmann B; Riecken EO
Gastroenterology; 1995 Nov; 109(5):1646-60. PubMed ID: 7557150
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of pancreatic carcinoma induced by retinoic acid or sodium butyrate: a morphological and molecular analysis of four cell lines.
Egawa N; Maillet B; VanDamme B; De Grève J; Klöppel G
Virchows Arch; 1996 Sep; 429(1):59-68. PubMed ID: 8865855
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma.
Köpf-Maier P
Anticancer Res; 1999; 19(1A):493-504. PubMed ID: 10226588
[TBL] [Abstract][Full Text] [Related]
17. [DNA ploidy of stem cells and prognosis of ductal adenocarcinoma of the pancreas].
Mellin W; Meyer J; Sasse W
Zentralbl Pathol; 1994 Aug; 140(3):237-42. PubMed ID: 7947631
[TBL] [Abstract][Full Text] [Related]
18. Integrin alpha6beta1 role in metastatic behavior of human pancreatic carcinoma cells.
Vogelmann R; Kreuser ED; Adler G; Lutz MP
Int J Cancer; 1999 Mar; 80(5):791-5. PubMed ID: 10048983
[TBL] [Abstract][Full Text] [Related]
19. Establishment of six human pancreatic cancer cell lines and their sensitivities to anti-tumor drugs.
Kobari M; Hisano H; Matsuno S; Sato T; Kan M; Tachibana T
Tohoku J Exp Med; 1986 Nov; 150(3):231-48. PubMed ID: 3547771
[TBL] [Abstract][Full Text] [Related]
20. Drug efflux transporter multidrug resistance-associated protein 5 affects sensitivity of pancreatic cancer cell lines to the nucleoside anticancer drug 5-fluorouracil.
Nambaru PK; Hübner T; Köck K; Mews S; Grube M; Payen L; Guitton J; Sendler M; Jedlitschky G; Rimmbach C; Rosskopf D; Kowalczyk DW; Kroemer HK; Weiss FU; Mayerle J; Lerch MM; Ritter CA
Drug Metab Dispos; 2011 Jan; 39(1):132-9. PubMed ID: 20930123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
